公开(公告)号：CA2602155A1

公开(公告)日：2006-10-05

申请号：CA2602155

申请日：2006-03-27

Applicant: BASF AG

Inventor： BECKER HEIKE ,  SUBKOWSKI THOMAS ,  BOLLSCHWEILER CLAUS ,  LEMAIRE HANS-GEORG ,  BAUS ULF ,  KAROS MARVIN

IPC: C11D3/38

Abstract: Use of hydrophobins for soil-repellent treatment of hard surfaces, in particular in combination with a cleansing of the surface, processes for soil-repellent treatment of hard surfaces, cleansing agents for hard surfaces and also hard surfaces with a soil-repellent coating comprising hydrophobins.

公开(公告)号：CA2599985A1

公开(公告)日：2006-10-05

申请号：CA2599985

申请日：2006-03-29

Applicant: BASF AG

Inventor： KORMANN CLAUDIUS ,  KIEFER MATTHIAS ,  KAROS MARVIN ,  LEMAIRE HANS-GEORG ,  BAUS ULF ,  SUBKOWSKI THOMAS ,  POSSELT DIETMAR ,  BOLLSCHWEILER CLAUS ,  GUZMANN MARCUS ,  SCHMITT WERNER

IPC: B01D17/04 ,  B01D17/05 ,  C07K14/375 ,  C10G33/04 ,  C10L1/22 ,  C10L1/24 ,  C10L1/26

Abstract: The present invention relates to the use of at least one protein, in particular at least one hydrophobin or at least one derivative thereof, for improving phase separation in compositions comprising at least two liquid phases, to methods for separating at least two liquid phases in a composition comprising at least two liquid phases, and to formulations comprising at least one compound selected from the group consisting of fuels, combustibles, crude oils or water-soluble or oil-soluble polymer solutions and at least one protein, in particular at least one hydrophobin or derivatives thereof.

公开(公告)号：NO310497B1

公开(公告)日：2001-07-16

申请号：NO964121

申请日：1996-09-27

Applicant: BASF AG

Inventor： BAUMANN ERNST ,  VOGELBACHER UWE JOSEF ,  RHEINHEIMER JOACHIM ,  KLINGE DAGMAR ,  RIECHERS HARTMUT ,  KROEGER BURKHARD ,  BIALOJAN SIEGFRIED ,  BOLLSCHWEILER CLAUS ,  WERNET WOLFGANG ,  UNGER LILIANE ,  RASCHACK MANFRED

IPC: A61K31/00 ,  A61K31/505 ,  A61K31/506 ,  C07D251/26 ,  A61K31/53 ,  A61P9/00 ,  A61P9/08 ,  A61P9/10 ,  A61P9/12 ,  A61P11/08 ,  A61P13/02 ,  A61P15/00 ,  A61P25/04 ,  A61P39/02 ,  C07D239/26 ,  C07D239/34 ,  C07D239/38 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D413/12 ,  C07D417/12

Abstract: PCT No. PCT/EP95/01099 Sec. 371 Date Sep. 30, 1996 Sec. 102(e) Date Sep. 30, 1996 PCT Filed Mar. 23, 1995 PCT Pub. No. WO95/26716 PCT Pub. Date Oct. 12, 1995A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I I

公开(公告)号：DK0716705T3

公开(公告)日：2000-07-10

申请号：DK94927528

申请日：1994-09-01

Applicant: BASF AG ,  RHEIN BIOTECH PROZ & PROD GMBH

Inventor： SCHWEDEN JUERGEN ,  BOLLSCHWEILER CLAUS ,  PIONTEK MICHAEL ,  WEYDEMANN ULRIKE ,  JANOWICZ ZBIGNIEW A ,  STRASSER ALEXANDER W M

IPC: C12N15/09 ,  C07K14/815 ,  C12N1/19 ,  C12N9/34 ,  C12N15/62 ,  C12N15/81 ,  C12P21/02 ,  C12R1/78

Abstract: PCT No. PCT/EP94/02897 Sec. 371 Date Mar. 1, 1996 Sec. 102(e) Date Mar. 1, 1996 PCT Filed Sep. 1, 1994 PCT Pub. No. WO95/07356 PCT Pub. Date Mar. 16, 1995A process for the recombinant production of proteins in the yeast Hansenula comprises transforming Hansenula with an expression cassette which comprises the following structural elements encoded: L-A-P-GEN where L is a leader sequence, A is an adaptor producing an alpha-helix structure, P is a processing signal and GEN is a structural gene for the required protein.

公开(公告)号：DE59409242D1

公开(公告)日：2000-04-27

申请号：DE59409242

申请日：1994-09-01

Applicant: BASF AG ,  RHEIN BIOTECH PROZ & PROD GMBH

Inventor： SCHWEDEN JUERGEN ,  BOLLSCHWEILER CLAUS ,  PIONTEK MICHAEL ,  WEYDEMANN ULRIKE ,  JANOWICZ ZBIGNIEW A ,  STRASSER ALEXANDER W M

IPC: C12N15/09 ,  C07K14/815 ,  C12N1/19 ,  C12N9/34 ,  C12N15/62 ,  C12N15/81 ,  C12P21/02 ,  C12R1/78

Abstract: PCT No. PCT/EP94/02897 Sec. 371 Date Mar. 1, 1996 Sec. 102(e) Date Mar. 1, 1996 PCT Filed Sep. 1, 1994 PCT Pub. No. WO95/07356 PCT Pub. Date Mar. 16, 1995A process for the recombinant production of proteins in the yeast Hansenula comprises transforming Hansenula with an expression cassette which comprises the following structural elements encoded: L-A-P-GEN where L is a leader sequence, A is an adaptor producing an alpha-helix structure, P is a processing signal and GEN is a structural gene for the required protein.

公开(公告)号：CZ9802477A3

公开(公告)日：1999-03-17

申请号：CZ247798

申请日：1997-02-11

Applicant: BASF AG

Inventor： RADITSCH MARTIN ,  FRIEDRICH THOMAS ,  BOLLSCHWEILER CLAUS ,  SCHMIDT MARTIN ,  HOFFKEN HANS WOLFGANG ,  SCHWEDEN JURGEN ,  RUBSAMEN KLAUS

IPC: C12N15/09 ,  A61K31/00 ,  A61K38/00 ,  A61K38/46 ,  A61P7/00 ,  A61P7/04 ,  C07K14/47 ,  C12N9/74 ,  C12N15/00 ,  C12N15/57 ,  C12R1/91 ,  A61K38/48

CPC classification number: C12N9/6429 ,  A61K38/00 ,  C12Y304/21005

公开(公告)号：NO983677D0

公开(公告)日：1998-08-11

申请号：NO983677

申请日：1998-08-11

Applicant: BASF AG

Inventor： RADITSCH MARTIN ,  FRIEDRICH THOMAS ,  BOLLSCHWEILER CLAUS ,  SCHMIDT MARTIN ,  HOEFFKEN HANS WOLFGANG ,  SCHWEDEN JUERGEN ,  RUEBSAMEN KLAUS

IPC: C12N15/09 ,  A61K31/00 ,  A61K38/00 ,  A61K38/46 ,  A61P7/00 ,  A61P7/04 ,  C07K14/47 ,  C12N9/74 ,  C12N15/00 ,  C12N15/57 ,  C12R1/91 ,  C12N

Abstract: PCT No. PCT/EP97/00612 Sec. 371 Date Aug. 4, 1998 Sec. 102(e) Date Aug. 4, 1998 PCT Filed Feb. 11, 1997 PCT Pub. No. WO97/29198 PCT Pub. Date Aug. 14, 1997The invention concerns thrombin muteins which have the following differences in their sequences as compared with natural thrombin: (a) the exchange of a Gly after Ala, the Gly being in the sequence environment Tyr-Gly-Phe and having position 558 in natural human thrombin (SEQ ID No. 14); (b) at least one exchange or deletion of the following radicals: (b1) His, located in the sequence environment Ala-His-Cys and having position 363 in natural human thrombin (SEQ ID No. 14); (b2) Asp, located in the sequence environment Arg-Asp-Ile and having position 419 in natural human thrombin (SEQ ID No. 14); (b3) Ser, located in the sequence environment Asp-Ser-Gly and having position 525 in natural human thrombin (SEQ ID No. 14). The invention further concerns the use of these muteins as antidotes.

公开(公告)号：HRP970077A2

公开(公告)日：1998-04-30

申请号：HRP970077

申请日：1997-02-11

Applicant: BASF AG

Inventor： RADITSCH MARTIN ,  FRIEDRICH THOMAS ,  BOLLSCHWEILER CLAUS ,  SCHMIDT MARTIN ,  HOEFFKEN HANS WOLFGANG ,  SCHWEDEN JUERGEN ,  RUEBSAMEN KLAUS

IPC: C12N15/09 ,  A61K31/00 ,  A61K38/00 ,  A61K38/46 ,  A61P7/00 ,  A61P7/04 ,  C07K14/47 ,  C12N9/74 ,  C12N15/00 ,  C12N15/57 ,  C12R1/91 ,  A61K38/48

Abstract: PCT No. PCT/EP97/00612 Sec. 371 Date Aug. 4, 1998 Sec. 102(e) Date Aug. 4, 1998 PCT Filed Feb. 11, 1997 PCT Pub. No. WO97/29198 PCT Pub. Date Aug. 14, 1997The invention concerns thrombin muteins which have the following differences in their sequences as compared with natural thrombin: (a) the exchange of a Gly after Ala, the Gly being in the sequence environment Tyr-Gly-Phe and having position 558 in natural human thrombin (SEQ ID No. 14); (b) at least one exchange or deletion of the following radicals: (b1) His, located in the sequence environment Ala-His-Cys and having position 363 in natural human thrombin (SEQ ID No. 14); (b2) Asp, located in the sequence environment Arg-Asp-Ile and having position 419 in natural human thrombin (SEQ ID No. 14); (b3) Ser, located in the sequence environment Asp-Ser-Gly and having position 525 in natural human thrombin (SEQ ID No. 14). The invention further concerns the use of these muteins as antidotes.

公开(公告)号：DK0609242T3

公开(公告)日：1997-01-06

申请号：DK92919916

申请日：1992-09-21

Applicant: BASF AG

Inventor： BIALOJAN SIEGFRIED ,  FRIEDRICH THOMAS ,  BOLLSCHWEILER CLAUS ,  KUENAST CHRISTOPH

IPC: A61K35/64 ,  A61K38/00 ,  A61K38/55 ,  A61P7/02 ,  C07K14/435 ,  C07K14/81 ,  C12N15/09 ,  C12N15/15 ,  C12P21/02 ,  C12R1/19 ,  A61K37/64

公开(公告)号：HU9602695D0

公开(公告)日：1996-11-28

申请号：HU9602695

申请日：1995-03-23

Applicant: BASF AG

Inventor： BAUMANN ERNST ,  BIALOJAN SIEGFRIED ,  BOLLSCHWEILER CLAUS ,  KLINGE DAGMAR ,  KROEGER BURKHARD ,  RASCHACK MANFRED ,  RHEINHEIMER JOACHIM ,  RIECHERS HARTMUT ,  UNGER LILIANE ,  VOGELBACHER UWE JOSEF ,  WERNET WOLFGANG

IPC: C07D251/26 ,  A61K31/00 ,  A61K31/505 ,  A61K31/506 ,  A61K31/53 ,  A61P9/00 ,  A61P9/08 ,  A61P9/10 ,  A61P9/12 ,  A61P11/08 ,  A61P13/02 ,  A61P15/00 ,  A61P25/04 ,  A61P39/02 ,  C07D239/26 ,  C07D239/34 ,  C07D239/38 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D413/12 ,  C07D417/12

Abstract: PCT No. PCT/EP95/01099 Sec. 371 Date Sep. 30, 1996 Sec. 102(e) Date Sep. 30, 1996 PCT Filed Mar. 23, 1995 PCT Pub. No. WO95/26716 PCT Pub. Date Oct. 12, 1995A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I I